Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 121 AL 135

Profiles of white matter tract pathology in frontotemporal dementia

Mahoney CJ, Ridgway GR, Malone IB, Downey LE, Beck J, Kinnunen KM, Schmitz N, Golden HL, Rohrer JD, Schott JM, Rossor MN, Ourselin S, Mead S, Fox NC, Warren JD.

Hum Brain Mapp. 2014 Aug;35(8):4163-79. doi: 10.1002/hbm.22468. Epub 2014 Feb 7.

Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease

Hong L, Huang HC, Jiang ZF.

Neurol Res. 2014 Mar;36(3):276-82. doi: 10.1179/1743132813Y.0000000288.

Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis

Bandyopadhyay S, Rogers JT.

Biochem Pharmacol. 2014 Apr 15;88(4):486-94. doi: 10.1016/j.bcp.2014.01.032. Epub 2014 Feb 7.

Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease

Ponnayyan Sulochana S, Sharma K, Mullangi R, Sukumaran SK.

Biomed Chromatogr. 2014 Nov;28(11):1431-90. doi: 10.1002/bmc.3116. Epub 2014 Feb 11.

The structural biology of the amyloid precursor protein APP - a complex puzzle reveals its multi-domain architecture

Coburger I, Hoefgen S, Than ME.

Biol Chem. 2014 May;395(5):485-98. doi: 10.1515/hsz-2013-0280.

Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease

Dawkins E, Small DH.

J Neurochem. 2014 Jun;129(5):756-69. doi: 10.1111/jnc.12675. Epub 2014 Mar 7.

Zinc and its effects on oxidative stress in Alzheimer's disease

Yuan Y, Niu F, Liu Y, Lu N.

Neurol Sci. 2014 Jun;35(6):923-8. doi: 10.1007/s10072-014-1668-x. Epub 2014 Feb 13.

Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines

Davtyan H, Bacon A, Petrushina I, Zagorski K, Cribbs DH, Ghochikyan A, Agadjanyan MG.

Hum Vaccin Immunother. 2014;10(5):1248-55. doi: 10.4161/hv.27882. Epub 2014 Feb 13.

Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms

Guerrero-Berroa E, Schmeidler J, Beeri MS.

Eur Neuropsychopharmacol. 2014 Dec;24(12):1961-6. doi: 10.1016/j.euroneuro.2014.01.019. Epub 2014 Jan 30.

The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease

Talbot K, Wang HY.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S12-25. doi: 10.1016/j.jalz.2013.12.007.

How does brain insulin resistance develop in Alzheimer's disease?

De Felice FG, Lourenco MV, Ferreira ST.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S26-32. doi: 10.1016/j.jalz.2013.12.004.

Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

Ferreira ST, Clarke JR, Bomfim TR, De Felice FG.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S76-83. doi: 10.1016/j.jalz.2013.12.010.

Sources of extracellular tau and its signaling

Avila J, Simón D, Díaz-Hernández M, Pintor J, Hernández F.

J Alzheimers Dis. 2014;40 Suppl 1:S7-S15. doi: 10.3233/JAD-131832.

Vaccination against Alzheimer disease: an update on future strategies

Fettelschoss A, Zabel F, Bachmann MF.

Hum Vaccin Immunother. 2014;10(4):847-51. doi: 10.4161/hv.28183. Epub 2014 Feb 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias